Stock Analysis
- Canada
- /
- Medical Equipment
- /
- TSXV:THRM
Therma Bright Full Year 2024 Earnings: CA$0.008 loss per share (vs CA$0.016 loss in FY 2023)
Therma Bright (CVE:THRM) Full Year 2024 Results
Key Financial Results
- Net loss: CA$2.45m (loss narrowed by 35% from FY 2023).
- CA$0.008 loss per share (improved from CA$0.016 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Therma Bright shares are up 10.0% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 5 warning signs for Therma Bright you should be aware of, and 4 of them shouldn't be ignored.
Valuation is complex, but we're here to simplify it.
Discover if Therma Bright might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSXV:THRM
Therma Bright
Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.